Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition
NCT01606059
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
DW-0920
DRUG:
DW-0919
Sponsor
Daewon Pharmaceutical Co., Ltd.
Collaborators
[object Object]